Ovid Therapeutics Inc. (OVID) vs Tectonic Therapeutic, Inc. (TECX)

A side-by-side comparison of Ovid Therapeutics Inc. and Tectonic Therapeutic, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OVID vs TECX

growth of $100 · dividends reinvested · last 8y
OVID -71.4% (-14.5%/yr)TECX -93.8% (-29.4%/yr)OVID compounded faster over this window
050100150Start $1002020202220242026$29$6
OVID TECX

OVID vs TECX: by the numbers

  • •OVID is the larger company ($442M vs $423M market cap).
  • •Both run net losses; TECX's is the smaller (0.00% vs -2178.90% net margin).

Metrics side by side

Valuation

MetricOVIDTECX
P/S ratio279.43N/A
P/B ratio2.111.89

Profitability

MetricOVIDTECX
Gross margin100.00%0.00%
Operating margin-585.20%0.00%
Net margin-2178.90%0.00%
ROE-16.43%-38.32%
ROIC-26.29%-41.88%

Growth (annualized)

MetricOVIDTECX
Revenue CAGR (5Y)-62.76%N/A
Total return CAGR (5Y)-6.98%-18.45%

Frequently asked

How have OVID and TECX total returns compared?
Over the past 5 years, OVID delivered -6.98% and TECX delivered -18.45% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.